“We all have a vested interest to stop this epidemic,” says Thomas Cueni, Director General of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA). As WHO on Tuesday convenes a Global Research & Innovation Forum to rapidly ramp up R&D, Cueni spoke with Health Policy Watch  about what he describes as  “the extraordinary willingness […] Continue reading ->
“Containment” remains the main objective of the battle against the coronavirus, said WHO’s Director General Dr Tedros Adhanom Ghebreyesus on Monday, following a weekend where reports of new virus clusters in the United Kingdom and France raised fresh concerns about the virus capacity to spread rapidly beyond China’s borders. The WHO Director General spoke to […] Continue reading ->
As the number of novel coronavirus infections rose again on Thursday – to 28,060 confirmed cases in China and 225 abroad – a US Centers for Disease Control official raised the possible spectre that the epidemic could become a global “pandemic” – if countries fail to take assertive action now. “While unclear how the situation […] Continue reading ->
In August, the Democratic Republic of the Congo (DRC) passed a milestone—surpassing 3,000 cases of Ebola since the outbreak began over a year ago. While the number of new infections has since slowed, there continue to be cases in hard to reach areas, posing challenges to response teams. The outbreak response has been complex, with […] Continue reading ->
[Sabin Vaccine Institute] LONDON / WASHINGTON, D.C. – GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed vaccines against these three viruses are currently available. […] Continue reading ->